ODC mRNA as a prognostic factor for predicting recurrence in meningiomas

Area of Science:

• Neuro-oncology
• Molecular Biology
• Biochemistry

Background:

• Ornithine decarboxylase (ODC) activity increases in proliferating neoplastic cells.
• ODC activation is observed in various brain tumors, including meningiomas.
• Investigating ODC gene expression in meningiomas is crucial for understanding tumor behavior.

Purpose of the Study:

• To investigate ornithine decarboxylase (ODC) gene expression at the transcriptional level in primary and recurrent meningiomas.
• To correlate ODC mRNA levels and activity with tumor recurrence and proliferation markers.
• To determine if ODC mRNA can serve as a prognostic factor for meningioma recurrence.

Main Methods:

• Quantification of ODC mRNA, ODC activity, mitosis count, and Ki-67 index in three meningioma groups: non-recurrent, recurrent, and their corresponding recurrent tumors.
• Statistical analysis to compare ODC mRNA levels and activity between groups.
• Median follow-up periods of 8.4 years for non-recurrent and 3.0 years for recurrent tumors were recorded.

Main Results:

• ODC mRNA levels were significantly higher in meningiomas with later recurrence compared to non-recurrent tumors (p < 0.01).
• ODC mRNA levels declined in recurrent tumors compared to their primary counterparts (p < 0.001).
• ODC activity increased significantly in recurrent tumors versus primary tumors (p < 0.001), while the Ki-67 index also showed a significant increase in recurrent tumors (p < 0.001).

Conclusions:

• ODC mRNA levels may serve as a prognostic factor for predicting meningioma recurrence.
• The findings highlight the role of ODC in meningioma progression and recurrence.
• Further research is warranted to validate ODC mRNA as a reliable biomarker for meningioma prognosis.